IS8390A - Notkun á gaboxadóli við meðhöndlun á svefnleysi - Google Patents

Notkun á gaboxadóli við meðhöndlun á svefnleysi

Info

Publication number
IS8390A
IS8390A IS8390A IS8390A IS8390A IS 8390 A IS8390 A IS 8390A IS 8390 A IS8390 A IS 8390A IS 8390 A IS8390 A IS 8390A IS 8390 A IS8390 A IS 8390A
Authority
IS
Iceland
Prior art keywords
gaboxadol
insomnia
treatment
Prior art date
Application number
IS8390A
Other languages
English (en)
Icelandic (is)
Inventor
Ebert Bjarke
Lundahl Jonas
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34684447&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS8390(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of IS8390A publication Critical patent/IS8390A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
IS8390A 2003-12-18 2006-03-30 Notkun á gaboxadóli við meðhöndlun á svefnleysi IS8390A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200301877 2003-12-18
PCT/DK2004/000861 WO2005058313A1 (en) 2003-12-18 2004-12-14 Use of gaboxadol for treating insomnia

Publications (1)

Publication Number Publication Date
IS8390A true IS8390A (is) 2006-03-30

Family

ID=34684447

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8390A IS8390A (is) 2003-12-18 2006-03-30 Notkun á gaboxadóli við meðhöndlun á svefnleysi

Country Status (17)

Country Link
EP (1) EP1720547A1 (pt)
JP (1) JP2007515415A (pt)
KR (1) KR20060103335A (pt)
CN (1) CN1893942A (pt)
AR (1) AR047154A1 (pt)
AU (1) AU2004298313A1 (pt)
BR (1) BRPI0415893A (pt)
CA (1) CA2550610A1 (pt)
EA (1) EA200600989A1 (pt)
IL (1) IL176239A0 (pt)
IS (1) IS8390A (pt)
MX (1) MXPA06006685A (pt)
NO (1) NO20063320L (pt)
SG (1) SG133601A1 (pt)
TW (1) TW200528098A (pt)
WO (1) WO2005058313A1 (pt)
ZA (1) ZA200602762B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0402118D0 (en) 2004-01-30 2004-03-03 Merck Sharp & Dohme Polymorphic forms of a GABAA agonist
WO2006118897A1 (en) * 2005-04-29 2006-11-09 H.Lundbeck A/S Acid and base salt forms of gaboxadol
CN111328282A (zh) * 2017-09-12 2020-06-23 奥维德医疗公司 加波沙朵在治疗发作性睡病中的用途
EP3833351A4 (en) 2018-09-20 2021-10-13 Ovid Therapeutics Inc. USE OF GABOXADOL TO TREAT TOURETTE SYNDROME, TICKS, AND STUTTERS
CN113423399A (zh) * 2018-12-17 2021-09-21 奥维德医疗公司 加波沙朵用于治疗非24小时睡眠-觉醒障碍的用途
CA3164635A1 (en) 2019-12-18 2021-06-24 Ovid Therapeutics Inc. Gaboxadol for therapeutic treatment of 1p36 deletion syndrome

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
PL366541A1 (en) * 2001-05-21 2005-02-07 H.Lundbeck A/S Granular preparations of gaboxadol

Also Published As

Publication number Publication date
ZA200602762B (en) 2007-06-27
IL176239A0 (en) 2006-10-05
WO2005058313A1 (en) 2005-06-30
JP2007515415A (ja) 2007-06-14
AR047154A1 (es) 2006-01-11
SG133601A1 (en) 2007-07-30
NO20063320L (no) 2006-07-18
BRPI0415893A (pt) 2007-01-09
CN1893942A (zh) 2007-01-10
TW200528098A (en) 2005-09-01
EP1720547A1 (en) 2006-11-15
KR20060103335A (ko) 2006-09-28
AU2004298313A1 (en) 2005-06-30
EA200600989A1 (ru) 2006-10-27
CA2550610A1 (en) 2005-06-30
MXPA06006685A (es) 2006-08-23

Similar Documents

Publication Publication Date Title
IL172316A0 (en) Novel compounds and their use in therapy
DK1636139T3 (da) Vandbehandlingsindretning
IL178012A0 (en) Diphenyl-indol-2-on compounds and their use in the treatment of cancer
DE60319810D1 (de) Anschwemmfiltermedien und herstellungs- und verwendungsverfahren
DE60315135D1 (de) Therapiesonde
IL180078A (en) Derivatives of 9-cis retinal for use in treating deficiency of 11-cis retinal
EE05505B1 (et) Personaalne teraapiasektsioon
GB0324761D0 (en) Use of compounds in therapy
IS8072A (is) Miðlar úr bak kólesteról flutningi í meðferð á kólesterólhækkun
IS7348A (is) N-pýrasínýl-fenýlsúlfónamíð og notkun þeirra til að meðhöndla flakkboðatengda sjúkdóma
DE602004010856D1 (de) Bohrlochbehandlungsflüssigkeiten
NO20050689L (no) Terapeutisk anvendelse
DK1678085T3 (da) Fluidbehandlingsindretning
IS7825A (is) Meðferðarfræðileg meðhöndlun
IS7444A (is) Morfólínýl-þvagefna afleiður til notkunar við meðhöndlun á bólguvaldandi sjúkdómum
IS8390A (is) Notkun á gaboxadóli við meðhöndlun á svefnleysi
DK1670482T4 (da) Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme
NO20055517D0 (no) 4-,6-O 7-hydroksyindoler med N-oksidgrupper og anvendelse av disse som terapeutiske midler
ATA13602003A (de) Therapeutisches behandlungsgerät
ITMI20030647A1 (it) Dispositivo per il trattamento di sangue in circolazione extracorporea
DE60329308D1 (de) Oberflächenbehandlung
IS7868A (is) Notkun á kortkólíberín-úrókortín kerfi í meðferð á bólguvaldandi sjúkdómum.
DK1496918T3 (da) Anvendelse af natriummetaarsenit til behandling af tumorer
TWI365187B (en) 7-azaindoles and the use thereof as therapeutic agents
IS8391A (is) Notkun á síramesíni við meðhöndlun á krabbameini